6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
16m ago	CC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
48m ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
48m ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
48m ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
49m ago	First Quantum Minerals Reports First Quarter 2026 Results

About

Medicinova Inc (NASDAQ:MNOV) — investor relations, events, news, and company updates on 6ix.

Latest News

New Peer‑Reviewed Study Reveals Actionable Immune–Microenvironment Target in Brain Metastasis; Medicinova Advances Clinical Translation

MediciNova to Participate at the 38th Annual ROTH Conference

MediciNova Announces 100 Patients Enrolled in SEANOBI Study Expanded-Access-Program (EAP) Evaluating MN‑166 (ibudilast) in ALS patients

2026 New Year’s Greetings from the CEO

MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Prevention of Chemotherapy-induced Peripheral Neuropathy

Financials

Revenue

$409.66 K

Market Cap

$69.4 M

EPS

-0.24

Community Chat

Ask AI